<?xml version="1.0" encoding="UTF-8"?>
<Label drug="diamox" track="TAC2017_ADR">
  <Text>
    <Section name="adverse reactions" id="S1">    Adverse Reactions

  Body as a whole:

   Headache, malaise, fatigue, fever, pain at injection site, flushing, growth retardation in children, flaccid paralysis, anaphylaxis.



   Digestive:

  Gastrointestinal disturbances such as nausea, vomiting, diarrhea.



   Hematological/Lymphatic:

  Blood dyscrasias such as aplastic anemia, agranulocytosis, leukopenia, thrombocytopenic purpura, melena.



   Hepato-biliary disorders:

  Abnormal liver function, cholestatic jaundice, hepatic insufficiency, fulminant hepatic necrosis.



   Metabolic/Nutritional:

  Metabolic acidosis, electrolyte imbalance, including hypokalemia, hyponatremia, osteomalacia with long-term phenytoin therapy, loss of appetite, taste alteration, hyper/hypoglycemia.



   Nervous:

  Drowsiness, paresthesia (including numbness and tingling of extremities and face), depression, excitement, ataxia, confusion, convulsions, dizziness.



   Skin:

  Allergic skin reactions including urticaria, photosensitivity, Stevens- Johnson syndrome, toxic epidermal necrolysis.



   Special senses:

  Hearing disturbances, tinnitus, transient myopia.



   Urogenital:

   Crystalluria, increased risk of nephrolithiasis with long-term therapy, hematuria, glycosuria, renal failure, polyuria.
</Section>
  </Text>
  <Mentions />
  <Relations />
  <Reactions />
</Label>
